Importance of drugs in breast cancer treatment

Since Breast cancer is one of the largest forms of cancer in the country, it has been affecting approximately over 0.21 million new female patients every year.

Apollo Hospitals launches genomics institute to provide comprehensive care to patients

Apollo Hospitals Navi Mumbai, an advanced quaternary care hospital launched the Apollo Genomics Institutes to provide comprehensive care to patients and families with genetic disorders...

IPEC India's virtual training series to focus on key global excipient regulations for generic drug development

The International Pharmaceutical Excipients Council (IPEC) India will host a virtual training series on February 9, 14, and 15, 2023, with a focus on key global excipient regulations for generic drug development...

Mark Cuban's pharmaceuticals startup ties up with RxPreferred

Mark Cuban's pharmaceuticals startup has partnered with pharmacy benefits manager RxPreferred Benefits, the companies announced, in an effort to offer lower-cost drugs through some employer-sponsored health insurance plans....

Sun Pharma launches Palbociclib to treat advanced breast cancer

Sun Pharmaceutical Industries Limited has announced that one of its wholly-owned subsidiaries has launched Palbociclib, a novel anti-cancer drug, in India for patients who have advanced breast cancer. The company will make the drug available under..

BioAsia 2023 to focus on opportunities in life science post-Covid

The event is scheduled to be held between February 24 and 26, at the Hyderabad International Convention Center (HICC) in Hyderabad. Ernst and Young will be the knowledge partner of the event...

Serum Institute of India's (SII) Covovax may get approval as heterologous booster

The government may decide on allowing Serum Institute of India’s (SII) Covovax as a heterologous booster dose, meaning it can be used for people who have taken either Covishield or Covaxin for primary vaccination against Covid-19...

Three Trends that will Impact Pharmaceutical Industry in 2023

In 2023, it is expected that the shift towards personalised medicine will continue as more and more pharmaceutical companies concentrate on creating medications that are customised for specific individuals.

Sirio Pharma completes acquisition of a majority stake in Best Formulations

Sirio Pharma Co., Ltd. (Sirio), a leading global CDMO, has announced the completion of its acquisition of a majority stake in Best Formulations LLC, a California-based contract manufacturer of nutritional supplements and personal care products...

Ocugen announced favourable Phase 2/3 research results for their COVID-19 vaccine candidate, COVAXIN

COVAXIN (BBV152; Clinicaltrials.gov, NCT05258669), a whole-virion inactivated COVID-19 investigational vaccine candidate that uses the same vero cell manufacturing platform that has been used in the production of polio vaccines for decades,...

© 2025 India Pharma Outlook. All Rights Reserved.